First line chemotherapy of metastatic breast cancer

P. Pronzato, M. Rondini

Research output: Contribution to journalArticlepeer-review


In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.

Original languageEnglish
JournalAnnals of Oncology
Issue numberSUPPL. 5
Publication statusPublished - May 2006


  • Chemotherapy
  • Metastatic breast cancer
  • Trastuzumab

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'First line chemotherapy of metastatic breast cancer'. Together they form a unique fingerprint.

Cite this